Avation Medical, Inc., a pioneering company in neuromodulation and digital health, is proud to announce the publication of safety and efficacy results from a multi-center study named «FREEOAB» for its innovative bladder control therapy Vivally System.

With millions of patients seeking relief from OAB symptoms without the risks or side effects associated with surgery or drugs, Vivally offers a promising solution. It offers a non-invasive, patient-centered approach to treatment, allowing patients to receive effective therapy in the comfort of their own homes, without the need for surgery or medication.

The Vivally System consists of a non-invasive bladder control therapy device and a companion mobile application. It is designed to treat patients with urge urinary incontinence (UUI) and urinary urgency caused by OAB. Unlike traditional treatments, Vivally does not require surgery, drugs, or needle-electrodes. The device is worn on the ankle and delivers therapy sessions lasting just 30 minutes, as little as once per week.

Results from the FREEOAB Study showed significant reductions in urinary frequency, incontinence, and urgency episodes at 12 weeks, along with improvements in quality of life measures. These positive outcomes were sustained at 12 months, with no significant adverse events related to the device reported. High compliance rates and satisfaction levels among patients further underscored the system’s effectiveness and ease of use.

Vivally is FDA-cleared and available by prescription in select areas of the United States. With its innovative approach to bladder control therapy, Avation Medical is poised to make a meaningful impact on the lives of patients suffering from OAB symptoms, providing them with a safe, effective, and convenient treatment option.

Article written by Michael Barbella